(Total Views: 429)
Posted On: 09/08/2019 7:29:07 AM
Post# of 156897
So who is Cydy negotiating with do you think?
We know Regeneron, Nanostring is in the mix from RP. We know they have had at least a conversation with ViiV and Gilead. With Carboplatin being used in the mTNBC trial, I say they probably had a conversation with Pfizer, but Pfizer and GSK partnered their HIV through ViiV, so I’m not sure with both cancer and hiv indications, who takes the lead there. Marshall and Colon Cancer, there is a Bayer connection, but that is remote and not through HIV. NP mentioned someone in Europe was interested and someone in Asia.
We also know there is the possibility of a bank, I believe, deal for first 250M in revenue. They had some discussions with Goldman Sachs from RP, maybe them on this deal?
Now that we know more, I need to find that list someone made after the May CC and start matching to see who is left.
Anyone else? NASH partner?
We know Regeneron, Nanostring is in the mix from RP. We know they have had at least a conversation with ViiV and Gilead. With Carboplatin being used in the mTNBC trial, I say they probably had a conversation with Pfizer, but Pfizer and GSK partnered their HIV through ViiV, so I’m not sure with both cancer and hiv indications, who takes the lead there. Marshall and Colon Cancer, there is a Bayer connection, but that is remote and not through HIV. NP mentioned someone in Europe was interested and someone in Asia.
We also know there is the possibility of a bank, I believe, deal for first 250M in revenue. They had some discussions with Goldman Sachs from RP, maybe them on this deal?
Now that we know more, I need to find that list someone made after the May CC and start matching to see who is left.
Anyone else? NASH partner?
(2)
(0)
